Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
WAIKOLOA, Hawaii — In this expert perspective from Retina 2026, Sunir J. Garg, MD, FACS, FASRS, discusses how real-world data have advanced treatment of retinal vascular diseases by increasing the number of available therapy options.
Garg, of Wills Eye Hospital, said patients with age-related macular degeneration or diabetes lose vision due to disease progression or undertreatment. However, the availability of newer therapies has improved anatomic outcomes and helped patients maintain vision.
“Some of our newer treatments would last longer, and that’s very helpful for patients,”